Stanford Health Policy Professor Debunks White House Claim COVID ‘A Far Greater Threat to Kids Than Flu’

As the White House anticipates approval of the Emergency Use Authorization (EUA) application for COVID vaccines for babies and young children, Dr. Jay Bhattacharya, professor of health policy at Stanford University, and a founding fellow at the Academy for Science and Freedom, says the claim that COVID is “a far greater threat to kids than the flu is” amounts to “scare-mongering.”

Bhattacharya responded in a column at the Wall Street Journal Sunday to White House COVID-19 Response Coordinator Dr. Ashish Jha’s recent tweet in which he made the claim “COVID is a far greater threat to kids than the flu is.”

Read More

Stanford Health Policy Professor Debunks White House Claim COVID ‘A Far Greater Threat to Kids Than Flu’

As the White House anticipates approval of the Emergency Use Authorization (EUA) application for COVID vaccines for babies and young children, Dr. Jay Bhattacharya, professor of health policy at Stanford University, and a founding fellow at the Academy for Science and Freedom, says the claim that COVID is “a far greater threat to kids than the flu is” amounts to “scare-mongering.”

Bhattacharya responded in a column at the Wall Street Journal Sunday to White House COVID-19 Response Coordinator Dr. Ashish Jha’s recent tweet in which he made the claim “COVID is a far greater threat to kids than the flu is.”

Read More

Pfizer Plan for COVID Vaccine Series for Babies of 6 Months Draws Fierce Controversy

closeup of a baby

Pfizer announced last week the Food and Drug Administration (FDA) had asked the drug company, and its partner BioNTech, to submit data on a COVID vaccine series for babies as young as 6 months old.

Albert Bourla, chairman and CEO of Pfizer, said in the statement:

As hospitalizations of children under 5 due to COVID-19 have soared, our mutual goal with the FDA is to prepare for future variant surges and provide parents with an option to help protect their children from this virus. Ultimately, we believe that three doses of the vaccine will be needed for children 6 months through 4 years of age to achieve high levels of protection against current and potential future variants. If two doses are authorized, parents will have the opportunity to begin a COVID-19 vaccination series for their children while awaiting potential authorization of a third dose.

Read More